Thymopoietin (TMPO) (N-Term) Peptide
TMPO
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN985276
Quick Overview for Thymopoietin (TMPO) (N-Term) Peptide (ABIN985276)
Target
Thymopoietin (TMPO)
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-TMPO antibody (Catalog #: ARP44798_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Thymopoietin (TMPO)
-
Background
-
TMPO may be involved in the structural organization of the nucleus and in the post-mitotic nuclear assembly. It plays an important role, together with LMNA, in the nuclear anchorage of RB1.
Alias Symbols: CMD1T, LAP2, MGC61508, PRO0868, TP, LEMD4
Protein Interaction Partner: RB1,AKAP8L,BANF1,GMCL1,LMNA,LMNB1,RB1,SGTA,SGTB,USP7,AKAP8L,BANF1,Gmcl1,LMNA,LMNB1,LMNB2,RB1
Protein Size: 345 -
Molecular Weight
- 39 kDa
-
Gene ID
- 7112
-
NCBI Accession
- NM_001032284, NP_001027455
Target
-
You are here:
